LAGUNA HILLS, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Sonendo®, Inc., the developer of a breakthrough technology for the dental marketplace, the GentleWave® System, today announced that Bjarne Bergheim, the Company’s President, and CEO, is scheduled to present at the Baird 2017 Global Health Conference in New York City on Wednesday, September 6, 2017, at 1:25 pm EDT.
About the event, Bjarne Bergheim stated, “We look forward to participating in this year’s conference and sharing some exciting milestones that will accelerate our growth expansion strategy.”
About Sonendo
Sonendo, Inc. is a privately-held company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science®. The first commercially available product from Sonendo, the GentleWave® System, available in the US, shows significant improvements in clinical efficacy, and treatment efficiency when compared to standard root canal techniques1-2. For more information, please visit www.sonendo.com.
1Sigurdsson A et al. (2016) J Endod. 42:1040-48. 2Molina B et al. (2015) J Endod. 41:1701-05.
Forward-Looking Statements
This announcement contains forward-looking statements based on management's beliefs, assumptions, and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.